Related references
Note: Only part of the references are listed.Safety and biomarker effects of Solanezumab in patients with Alzheimer's disease
Martin Farlow et al.
ALZHEIMERS & DEMENTIA (2012)
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
Kaj Blennow et al.
ARCHIVES OF NEUROLOGY (2012)
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
Frederique Bard et al.
EXPERIMENTAL NEUROLOGY (2012)
An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ
Oskar Adolfsson et al.
JOURNAL OF NEUROSCIENCE (2012)
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Bengt Winblad et al.
LANCET NEUROLOGY (2012)
US government sets out Alzheimer's plan
Meredith Wadman
NATURE (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Stopping Alzheimer's Before It Starts
Greg Miller
SCIENCE (2012)
Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
Adam S. Fleisher et al.
ARCHIVES OF NEUROLOGY (2011)
DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer's Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation
Doris Lambracht-Washington et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
Beneficial effect of human anti-amyloid-β active immunization on neurite morphology and tau pathology
Alberto Serrano-Pozo et al.
BRAIN (2010)
DNA prime-protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type mice
H. Davtyan et al.
GENE THERAPY (2010)
Analysis of three plasmid systems for use in DNA Aβ42 immunization as therapy for Alzheimer's disease
Bao-Xi Qu et al.
VACCINE (2010)
DNA β-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
Doris Lambracht-Washington et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
Norman R. Relkin et al.
NEUROBIOLOGY OF AGING (2009)
Reduced oligomeric and vascular amyloid-β following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine
Kevin A. DaSilva et al.
VACCINE (2009)
Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable A β1-15 reduces Aβ burden and behavioral impairment without Aβ-specific T cell response
Juntao Zou et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid β (1-42) plus CpG oligodeoxynucleotides in aged rats
Sarada Subramanian et al.
NEUROSCIENCE LETTERS (2008)
Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine - A Novel Immunotherapeutic Strategy
Nina Movsesyan et al.
PLOS ONE (2008)
Aβ42 gene vaccine prevents Aβ42 deposition in brain of double transgenic mice
Bao-Xi Qu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease
Hong-Duck Kim et al.
IMMUNOLOGY LETTERS (2007)
Novel AP immunogens: Is shorter better?
Cynthia A. Lemere et al.
CURRENT ALZHEIMER RESEARCH (2007)
Aβ42 gene vaccination reduces brain amyloid plaque burden in transgenic mice
Baoxi Qu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Short amyloid-β(Aβ) immunogens reduce cerebral Aβ load and learning deficits in an Alzheimer's disease mouse model in the absence of an Aβ-specific cellular immune response
M Maier et al.
JOURNAL OF NEUROSCIENCE (2006)
Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease
A Monsonego et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Translational research on the way to effective therapy for Alzheimer disease
RN Rosenberg
ARCHIVES OF GENERAL PSYCHIATRY (2005)
β-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease
M Buttini et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
NC Fox et al.
NEUROLOGY (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Jump-starting the immune system: prime-boosting comes of age
DL Woodland
TRENDS IN IMMUNOLOGY (2004)
Gene vaccination to bias the immune response to amyloid-β peptide as therapy for Alzheimer disease
BX Qu et al.
ARCHIVES OF NEUROLOGY (2004)
The current status of Alzheimer's disease genetics: what do we tell the patients?
L Bertram et al.
PHARMACOLOGICAL RESEARCH (2004)
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
A Monsonego et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
S Oddo et al.
NEUROBIOLOGY OF AGING (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
C Janus et al.
NATURE (2000)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Share Paper
